What is NDC 0093-5420?

0093-5420 is the product NDC for Cabergoline, Cabergoline .5 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cabergoline?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cabergoline NDC 0093-5420 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-5420Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-5420Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-5420-88	0009354208800093542088	1 BOTTLE in 1 CARTON (0093-5420-88) / 8 TABLET in 1 BOTTLEMarketed from Mar 7, 2007

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cabergoline
Generic name (nonproprietary): cabergoline
Active ingredients: Cabergoline — .5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077750
Marketing start: Mar 7, 2007
Listing expires: Dec 31, 2026
Other FDA classes: Ergolines (Chemical structure)
Identifiers: Product ID 0093-5420_ee38a597-4dd9-4b40-b168-97e919ead1c7SPL ID ee38a597-4dd9-4b40-b168-97e919ead1c7SPL set ID 74b61e8a-7ae9-4996-85ec-df23c56de16fRxCUI 199703UNII LL60K9J05T
Pharmacologic class: Ergot Derivative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093542088 followed by a unit qualifier and the quantity

Package 00093-5420-88. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 16, 2025.

Indications (excerpt from the label)

Cabergoline tablets are an ergot derivative indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas in adults. Limitations of Use Avoid use of cabergoline tablets for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious adverse reactions [see Warnings and Precautions (5.4)]. Cabergoline tablets are an ergot derivative indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas in adults. ( 1 ) Limitations of Use Avoid use of cabergoline tablets for the inhibition or suppression of postpartum physiologic lactation because of the risk of serious advers…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-5420

What is NDC 0093-5420?: 0093-5420 is the product NDC for Cabergoline, Cabergoline .5 mg/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cabergoline.
What is the active ingredient?: Cabergoline.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cabergoline?: 11 other product NDCs are listed under this name. See all Cabergoline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cabergoline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cabergoline	Cabergoline .5 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-315	27808-0315-01
Cabergoline	Cabergoline .5 mg/1	TabletOral	Somerset Therapeutics, LLC	70069-824	70069-0824-08
Cabergoline	Cabergoline .5 mg/1	TabletOral	A-S Medication Solutions	50090-7642	50090-7642-00
Cabergoline	Cabergoline .5 mg/1	TabletOral	Amneal Pharmaceuticals NY LLC	69238-2693	69238-2693-01
Cabergoline	Cabergoline .5 mg/1	TabletOral	SOLA Pharmaceuticals, LLC	70512-860	70512-0860-08
Cabergoline	Cabergoline .5 mg/1	TabletOral	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-823	23155-0823-73
Cabergoline	Cabergoline .5 mg/1	TabletOral	A-S Medication Solutions	50090-6596	50090-6596-00
Cabergoline	Cabergoline .5 mg/1	TabletOral	A-S Medication Solutions	50090-5834	50090-5834-00
Cabergoline	Cabergoline .5 mg/1	TabletOral	Ingenus Pharmaceuticals, LLC	50742-118	50742-0118-08
Cabergoline	Cabergoline .5 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1005	59762-1005-01

All 12 Cabergoline NDCs

Other NDCs under ANDA 077750

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077750
Product	Strength	Form · route	Labeler	Product NDC
Cabergoline	Cabergoline .5 mg/1	TabletOral	A-S Medication Solutions	50090-3157